Literature DB >> 18415470

[Clinical features, pathophysiology and treatment of fibromyalgia.].

H C Müller-Busch1.   

Abstract

In rheumatology, all of the more than 400 specified syndromes are associated with pain. In the conceptual discussion on the multidimensional influences postulated to explain the development of chronic pain, fibromyalgia has gained increasing interest. Fibromyalgia (fibrositis) is an unspecific soft-tissue disorder with chronic wide-spread musculoskeletal pain and palpable hypersensitivity at fibrositic tender points. Fibromyalgia is often associated with fatigue, nonrestorative sleep and other symptoms. The syndrome has a high prevalence in women, but in most cases it has a long course with unsatisfactory attempts at therapy before the diagnosis is made. Though diagnostic criteria have been defined to describe it as a distinct clinical syndrome, speculations on its aetiology and pathogenetic mechanisms are still controversial. Histochemical investigations on muscle biopsy and biochemical tests have revealed unspecific changes but no characteristic muscle abnormality. It is supposed that the clinical features may result from central neurohumoral dysfunction combining with peripheral mechanisms to result in hyperalgesia. An integrated therapeutic concept with a reassuring and positive doctor-patient relationship can be helpful in achieving satisfactory treatment results.

Entities:  

Year:  1994        PMID: 18415470     DOI: 10.1007/BF02530390

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  83 in total

1.  Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects.

Authors:  H Moldofsky; P Scarisbrick; R England; H Smythe
Journal:  Psychosom Med       Date:  1975 Jul-Aug       Impact factor: 4.312

2.  Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis.

Authors:  Henning Vaerøy; Robert Helle; Øystein Førre; Erik Kåss; Lars Terenius
Journal:  Pain       Date:  1988-01       Impact factor: 6.961

3.  Undetected fibrositis in primary care practice.

Authors:  A Hartz; E Kirchdoerfer
Journal:  J Fam Pract       Date:  1987-10       Impact factor: 0.493

Review 4.  [Psychosomatic aspects of muscle pain].

Authors:  M Ermann; J Scharfenstein
Journal:  Internist (Berl)       Date:  1987-10       Impact factor: 0.743

5.  Cognitive behavioral treatment of fibromyalgia syndrome: preliminary findings.

Authors:  W R Nielson; C Walker; G A McCain
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

Review 6.  The concept of primary fibromyalgia (fibrositis): clinical value, relation and significance to other chronic musculoskeletal pain syndromes.

Authors:  G A McCain; R A Scudds
Journal:  Pain       Date:  1988-06       Impact factor: 6.961

Review 7.  [Generalized tendomyopathy. I: Clinical aspects, follow-up and differential diagnosis].

Authors:  W Müller; J Lautenschläger
Journal:  Z Rheumatol       Date:  1990 Jan-Feb       Impact factor: 1.372

8.  Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.

Authors:  S Carette; G A McCain; D A Bell; A G Fam
Journal:  Arthritis Rheum       Date:  1986-05

9.  Electroacupuncture in fibromyalgia: results of a controlled trial.

Authors:  C Deluze; L Bosia; A Zirbs; A Chantraine; T L Vischer
Journal:  BMJ       Date:  1992-11-21

10.  Prevalence of primary and secondary fibrositis.

Authors:  F Wolfe; M A Cathey
Journal:  J Rheumatol       Date:  1983-12       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.